IP Library Granted Patent US 8,560,052
Granted Patent B2
US 8,560,052 · App. 10/828,539 · Granted Oct 15, 2013

Echogenic medical device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,560,052
App. No.
10/828,539
Filed
Apr 20, 2004
Granted
Oct 15, 2013
Kind
B2
Art Unit
3737
USPC
600/431
Abstract

Echogenic medical devices, methods of fabrication and methods of use are disclosed. The device can be adapted to be inserted into a patient. The echogenic construction can be incorporated into the device at the time of fabrication providing acoustic impedance different from that of the surrounding biological tissue or fluid. The medical device is designed for use with an ultrasound imaging system to provide real-time location of the insertion and guidance at the time the device is implanted in a patient, such as in brachytherapy. Following placement of the device the position can be evaluated over time to insure the device remains in proper alignment and functional. Furthermore, the device is designed to incorporate a spacer element at one or both ends to provide separation between radioactive elements.

Claims (42)

1. An implantable brachytherapy seed device configured to be imaged, the device comprising: a parabolic surface defining a hermetically sealed body chamber filled with a gas; and a radioisotopic component inside the body chamber that is surrounded by the gas wherein the gas has a density difference with the body chamber and the tissue into which the implantable brachytherapy seed device is implantable so that the implantable brachytherapy seed is more easily imagable using acoustic energy, the medical device having a proximal and a distal end and the medical device is capable of being implanted into a live body.

2. The device of claim 1 , where the radioisotopic component comprises 26 Al, 198 Au, 115 Cd, 137 Cs, 125 I, 192 Ir, 40 K, 32 P, 103 Pd, 86 Rb, 123 Sn, 89 Sr, 90 Sr, 125 Te, 90 Y, 91 Y, 169 Yb or a combination of these.

3. The device of claim 2 , where the radioisotopic component comprises 125 I or 103 Pd.

4. The device of claim 1 , where the device comprise at least one spacer element connected to the body chamber.

5. The device of claim 4 , further comprising at least one spacer element at the proximal end of the device.

6. The device of claim 4 , further comprising at least one spacer element at the said distal end of the device.

7. The device of claim 4 , further comprising a plurality of parabolic surfaces, each parabolic surface defining a body chamber.

8. The device of claim 7 , where one body chamber is connected to a spacer element that is connected to at least a second body chamber.

9. The device of claim 4 , the spacer element further comprising a contrast material.

10. The device of claim 9 , where the contrast material is silver, gold, or tungsten.

11. The device of claim 4 , further comprising a docking guide that is operatively attached to the spacer element or to the body chamber where the docking guide is at the proximal end of the device.

12. The device of claim 11 , wherein the docking guide accepts a radioactive source or a spacer.

13. The device of claim 11 , wherein the docking guide fixes the medical device in tissue when the medical device is implanted into a live body.

14. The device of claim 11 , where the docking guide comprises a flexible joint.

15. The device of claim 11 , where the docking guide comprises a non-locking docking port.

16. The device of claim 1 , further comprising a plurality of spacer elements.

17. The device of claim 16 , wherein the plurality of spacer elements further comprises at least one spacer element at the proximal end and at least one spacer element at the distal end of the device.

18. The device of claim 1 , further comprising a contrast material inside the body chamber.

19. The device of claim 18 , where the contrast material further comprises a nuclear magnetic imaging contrast material.

20. The device of claim 18 , where the contrast material further comprises a radiographic imaging contrast material.

21. The device of claim 1 , where the device has a density of between 0.5 and 1.5 g/ml.

22. The device of claim 1 , where the device has a density of between 0.8 and 1.2 g/ml.

23. The device of claim 1 , where the device has a density of between 0.9 and 1.1 g/ml.

24. The device of claim 1 , where the device comprises one or more synthetic polymers.

25. The device of claim 24 , where the polymer is selected from the group consisting of liquid crystal polymer (LCP), Teflon, carboxylic polymers, polyacetates, polyacrylics, polyacrylamides, polyamides, polyvinylbutyrals, polycarbonates, polyethylenes, polysilanes, polyureas, polyurethanes, polyethers, polyesters, polyoxides, polystyrenes, polysulfides, polysulfones, polysulfonides, polyvinylhalides, pyrrolidones, rubbers, and thermal-setting polymers.

26. The device of claim 25 , where the polymer is LCP.

27. The device of claim 26 , where the LCP is an extruded LCP.

28. The device of claim 1 , where the device comprises a material selected from the group consisting of albumin, cellulose, cellulose derivatives, gelatin, and gut.

29. The device of claim 1 , where the device comprises one or more metals.

30. The device of claim 29 , where the metal is titanium.

31. The device of claim 1 , further comprising one or more voids, bubbles or channels.

32. The device of claim 31 , where each void is between 0.1 mm and 0.9 mm in length.

33. The device of claim 32 , where each void is about 0.5 mm in length.

34. The device of claim 32 , comprising 1-10 voids.

35. The device of claim 34 , comprising 1 void.

36. The device of claim 31 , where each of the bubbles are between 0.001 and 0.1 mm in diameter.

37. The device of claim 36 , where each of the bubbles are about 0.01 mm in diameter.

38. The device of claim 31 , where each of the channels are between 0.001 and 0.1 mm in diameter.

39. The device of claim 38 , where each of the channels are about 0.01 mm in diameter.

40. The device of claim 38 , where each of the channels spiral at approximately 45 degree to the long axis.

41. The device of claim 1 , wherein the gas is air.

42. The device of claim 1 , wherein the gas is nitrogen.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2021
From: CONCURE ONCOLOGY, INC.
To: COWLES VENTURES, LLC
Reel/Frame 058443/0132 →
CHANGE OF NAME Recorded Aug 3, 2020
From: BREAST MICROSEED, INC.
To: CONCURE ONCOLOGY, INC.
Reel/Frame 053382/0324 →